These patients often develop multiple alterations at the vascular level, leading to endothelial dysfunction, coagulation abnormalities, insulin resistance, hyperhomocystinaemia and activation of the sympathetic nervous system, as well as the renin–angiotensin and aldosterone system. This evidence concerns the gene REN and endothelial dysfunction.